Dolphin Medical Services Ltd
Incorporated in 1984, Dolphin Medical Services Ltd is engaged in the business of Medical Laboratory Services.
- Market Cap ₹ 3.96 Cr.
- Current Price ₹ 2.62
- High / Low ₹ 3.25 / 1.50
- Stock P/E
- Book Value ₹ 8.45
- Dividend Yield 0.00 %
- ROCE -0.05 %
- ROE -0.39 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.31 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -32.5% over past five years.
- Promoter holding is low: 26.4%
- Company has a low return on equity of -3.73% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| 2.60 | 2.70 | 3.35 | 4.06 | 3.76 | 1.14 | 0.96 | 0.36 | 0.57 | |
| 2.07 | 2.14 | 2.24 | 2.82 | 2.83 | 1.73 | 1.06 | 0.39 | 0.39 | |
| Operating Profit | 0.53 | 0.56 | 1.11 | 1.24 | 0.93 | -0.59 | -0.10 | -0.03 | 0.18 |
| OPM % | 20.38% | 20.74% | 33.13% | 30.54% | 24.73% | -51.75% | -10.42% | -8.33% | 31.58% |
| 0.14 | 0.05 | 0.07 | 0.14 | -0.54 | -0.01 | 0.00 | 0.01 | 0.15 | |
| Interest | 0.11 | 0.02 | 0.54 | 0.67 | 1.19 | 0.70 | 0.05 | 0.05 | 0.06 |
| Depreciation | 0.31 | 0.39 | 0.57 | 0.59 | 0.65 | 0.65 | 0.71 | 0.52 | 0.34 |
| Profit before tax | 0.25 | 0.20 | 0.07 | 0.12 | -1.45 | -1.95 | -0.86 | -0.59 | -0.07 |
| Tax % | 44.00% | 35.00% | 228.57% | 100.00% | 2.76% | 1.54% | 0.00% | -3.39% | -28.57% |
| 0.14 | 0.13 | -0.09 | 0.00 | -1.49 | -1.98 | -0.86 | -0.57 | -0.05 | |
| EPS in Rs | 0.09 | 0.09 | -0.06 | 0.00 | -0.99 | -1.31 | -0.57 | -0.38 | -0.03 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -32% |
| 3 Years: | -21% |
| TTM: | 58% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 25% |
| TTM: | 91% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 42% |
| 3 Years: | -3% |
| 1 Year: | 67% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -6% |
| 3 Years: | -4% |
| Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 |
| Reserves | 2.25 | 2.38 | 2.61 | 2.61 | 1.12 | -0.86 | -1.72 | -2.30 | -2.34 |
| 0.17 | 5.49 | 6.94 | 6.99 | 7.69 | 8.24 | 8.10 | 8.05 | 8.16 | |
| 0.77 | 0.77 | 0.63 | 0.86 | 0.79 | 0.82 | 0.83 | 0.82 | 0.75 | |
| Total Liabilities | 18.29 | 23.74 | 25.28 | 25.56 | 24.70 | 23.30 | 22.31 | 21.67 | 21.67 |
| 7.47 | 8.50 | 12.14 | 15.69 | 11.40 | 11.94 | 11.23 | 14.69 | 14.34 | |
| CWIP | 0.00 | 8.14 | 6.64 | 3.28 | 7.29 | 6.10 | 6.11 | 2.14 | 2.14 |
| Investments | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| 10.41 | 6.69 | 6.09 | 6.18 | 5.60 | 4.85 | 4.56 | 4.43 | 4.78 | |
| Total Assets | 18.29 | 23.74 | 25.28 | 25.56 | 24.70 | 23.30 | 22.31 | 21.67 | 21.67 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| 2.00 | 1.36 | 0.00 | 1.30 | 0.15 | 0.19 | -0.12 | |||
| -9.57 | -3.23 | 0.00 | -0.50 | -0.12 | -0.17 | 0.01 | |||
| 5.19 | 1.37 | 0.00 | -0.88 | -0.03 | -0.02 | 0.11 | |||
| Net Cash Flow | -2.38 | -0.50 | 0.00 | -0.08 | 0.00 | 0.00 | 0.00 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 13.86 | 21.22 | 45.62 | 36.50 | 36.50 | 21.47 | |||
| Days Payable | 13.86 | 4.24 | 0.00 | 12.17 | 73.00 | 0.00 | |||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.90 | 16.98 | 45.62 | 24.33 | -36.50 | 21.47 |
| Working Capital Days | 1,037.44 | 462.33 | 306.16 | 273.30 | 250.45 | 589.12 | 589.32 | 1,449.86 | 1,171.84 |
| ROCE % | 1.09% | 2.56% | 3.20% | 1.15% | -5.33% | -3.67% | -2.54% | -0.05% |
Documents
Announcements
- Results For The Quarter And Half Year Ended September 30, 2024 12 Nov
-
Board Meeting Outcome for Board Meeting Outcome For Standalone Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
12 Nov - Submission of unaudited financial results for Q2 2024.
-
Board Meeting Intimation for Unaudited Results For The Quarter Ended 30.09.2024
5 Nov - Board meeting to consider Q2 financial results.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 1 Nov
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
31 Oct - Submission of Scrutinizer Report for 32nd AGM.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company provides comprehensive Diagnostic Services, with a range of tests covering Radiology and Imaging, Pathology, Biochemistry and Microbiology etc., in Andhra Pradesh.